
InterHealth Nutraceuticals Profile last edited on: 12/14/17
CAGE: 4H2C5
UEI:
Business Identifier: Ingredients for dietary supplements and functional foods Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
Location Information
Location: Single
Congr. District: 05
County: Solano
Congr. District: 05
County: Solano
Public Profile
In mid-August 2016, InterHealth was acquired By Switzerland-listed Lonza Group Ltd. Interealth specializes in proprietary, value-added nutritional ingredients, including Zychromeâ¢, LOWATâ¢, Super CitriMax®, ChromeMate®, L-OptiZinc®, Protykin®, ZMA®, UC-II®, OptiBerry®, Aller-7® and others. Currently, InterHealth's ingredients are incorporated in more than 600 nutritional products distributed in more than 30 countries around the world under such brands as Metabolife, Natureâs Way Alive, Natrol, Now Foods, SO-BE Lean, and Skinny Water. Punctuating the company's success is its co-branding marketing program. InterHealth creates brand names and logos for its proprietary ingredients, which help consumers and retailers identify products that contain InterHealth ingredients. Manufacturers that use InterHealth ingredients and display the ingredient logos on their finished product labels and advertising materials benefit from the brand awareness and end-user demand created by the various advertising and public relations activities InterHealth uses to promote its ingredients to consumers and retailers. The firm supports an extensive product research program, actively sponsors original independent university studies on its products, which are used to evaluate safety and efficacy, and to support its product structure/function claims. InterHealth has sponsored research on its ingredients at more than a dozen universities, which has resulted in more than 100 research presentations, publications and abstracts presented at leading scientific conferences or published in peer-reviewed scientif
Extent of SBIR involvement
Synopsis: Awardee Business Condition
Employee Range
25-49Revenue Range
2.5M-5MVC funded?
NoPublic/Private
Privately HeldStock Info
----IP Holdings
20-24Awards Distribution by Agency
Most Recent SBIR Projects
Year | Phase | Agency | Total Amount | |
---|---|---|---|---|
2004 | 1 | NIH | $149,800 | |
Project Title: Resveratrol as a Pharmacological Preconditioning Agent |
Key People / Management
William A Seroy -- President
Debasis Bagchi
Paul Dijkstra -- Chief Executive Officer
Mary Helen Lucero -- Chief Financial Officer
James Lugo -- Director, Business Development and Research
Jay Martin -- VP Sales & Marketing
Massood Moshrefi -- Vice President of Operations
Debasis Bagchi
Paul Dijkstra -- Chief Executive Officer
Mary Helen Lucero -- Chief Financial Officer
James Lugo -- Director, Business Development and Research
Jay Martin -- VP Sales & Marketing
Massood Moshrefi -- Vice President of Operations